The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis is sponsored by BrightFocus Foundation. Studies how the nuclear receptor RORa links lipid dysregulation to inflammation in AMD.

The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis Grants > The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis Macular Degeneration Research Grant The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis Drusen Formation & Immune Response Boston Children’s Hospital Macular Degeneration Research July 01, 2024 - June 30, 2026 This grant is made possible by the support of the Free Family Foundation.

Jing Chen, PhD, Boston Children’s Hospital, Harvard Medical School This project aims to uncover the mechanisms by which a lipid-sensing nuclear receptor RORa links lipid dysregulation with abnormal macrophage recruitment and chronic inflammation in AMD pathogenesis. Age-related macular degeneration (AMD) is a leading cause of blindness among people aged 60 and older.

It is a multifactorial disease involving multiple cellular pathways, among which lipid dysregulation and inflammation are major pathogenic factors. Researchers will investigate the role of a lipid-sensing nuclear receptor retinoic acid-related orphan receptor alpha (RORa) in regulating chronic subretinal inflammation to elucidate AMD pathogenesis.

They will assess if genetic deletion of RORa in a type of inflammatory cells may lead to lipid dysregulation and chronic inflammation. Lipid dysregulation is implicated in AMD pathogenesis, yet the mechanisms through which lipid dysregulation in macrophages/microglia leads to chronic inflammation impact AMD is not fully clear.

This research proposal aims to fill this knowledge gap by investigating a novel role of a nuclear receptor retinoic acid-related orphan receptor alpha (RORa) that may link lipid dysregulation and chronic subretinal inflammation involving macrophage/microglia in AMD pathogenesis. This project will provide a potential new druggable target RORa in resolving chronic inflammation in AMD.

Successful completion of this proposal will advance the field of AMD research by uncovering new knowledge on how a novel lipid regulator RORa may transcriptionally link lipid dysregulation and chronic inflammation in early AMD disease processes. Such information may provide new breakthroughs and new druggable molecular targets for designing potential AMD therapies.

Macular Degeneration Research How Aging of the Immune System Affects Age-Related Macular Degeneration July 01, 2025 - June 30, 2028 Macular Degeneration Research Microglia’s Roles in AMD to Inform Therapies for Vision Loss Prevention July 01, 2025 - June 30, 2027 Duke University School of Medicine Macular Degeneration Research Exosomes and Autophagy: Suspicious Partners in Drusen Biogenesis and AMD July 01, 2024 - June 30, 2027 Miguel Flores Bellver, PhD University of Colorado Anschutz Medical Campus News Featuring This Grantee How Understanding Lipid Processing in the Eye Could Spark Innovative AMD Treatment Approaches With the help of funding from Macular Degeneration Research, Dr. Neetu Kushwah is studying the link between abnormal lipid regulation in the eye, inflammation, and age-related macular degeneration.

Her findings could inspire new methods for treating the disease.